APA (7th ed.) Citation

Saverio Candido, Rossella Salemi, Sara Piccinin, Luca Falzone, & Massimo Libra. (2022). The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K-Akt Pathways. MDPI AG.

Chicago Style (17th ed.) Citation

Saverio Candido, Rossella Salemi, Sara Piccinin, Luca Falzone, and Massimo Libra. The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells Through the Cross-Activation of MAPK and PI3K-Akt Pathways. MDPI AG, 2022.

MLA (9th ed.) Citation

Saverio Candido, et al. The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells Through the Cross-Activation of MAPK and PI3K-Akt Pathways. MDPI AG, 2022.